An Oncogenic Role for the Ubiquitin Ligase UBE2O by Targeting AMPK-α2 for Degradation

D. Grahame Hardie (Lead / Corresponding author)

Research output: Contribution to journalArticle

1 Citation (Scopus)
21 Downloads (Pure)

Abstract

There has been controversy regarding the role of AMPK in cancer, some of which may be due to functional differences between isoforms. In this issue of Cancer Cell, Vila et al. report that UBE2O, a ubiquitin ligase overexpressed in some human cancers, specifically triggers the ubiquitination and degradation of AMPK-α2.

Original languageEnglish
Pages (from-to)163-165
Number of pages3
JournalCancer Cell
Volume31
Issue number2
DOIs
Publication statusPublished - 13 Feb 2017

Fingerprint

AMP-Activated Protein Kinases
Ligases
Ubiquitin
Neoplasms
Ubiquitination
Protein Isoforms

Cite this

@article{bec364209b3c4bcaa4f333ce4139c871,
title = "An Oncogenic Role for the Ubiquitin Ligase UBE2O by Targeting AMPK-α2 for Degradation",
abstract = "There has been controversy regarding the role of AMPK in cancer, some of which may be due to functional differences between isoforms. In this issue of Cancer Cell, Vila et al. report that UBE2O, a ubiquitin ligase overexpressed in some human cancers, specifically triggers the ubiquitination and degradation of AMPK-α2.",
author = "Hardie, {D. Grahame}",
note = "D.G.H. is a Wellcome Trust Investigator and is also supported by Cancer Research UK. - A Preview",
year = "2017",
month = "2",
day = "13",
doi = "10.1016/j.ccell.2017.01.010",
language = "English",
volume = "31",
pages = "163--165",
journal = "Cancer Cell",
issn = "1535-6108",
publisher = "Elsevier",
number = "2",

}

An Oncogenic Role for the Ubiquitin Ligase UBE2O by Targeting AMPK-α2 for Degradation. / Hardie, D. Grahame (Lead / Corresponding author).

In: Cancer Cell, Vol. 31, No. 2, 13.02.2017, p. 163-165.

Research output: Contribution to journalArticle

TY - JOUR

T1 - An Oncogenic Role for the Ubiquitin Ligase UBE2O by Targeting AMPK-α2 for Degradation

AU - Hardie, D. Grahame

N1 - D.G.H. is a Wellcome Trust Investigator and is also supported by Cancer Research UK. - A Preview

PY - 2017/2/13

Y1 - 2017/2/13

N2 - There has been controversy regarding the role of AMPK in cancer, some of which may be due to functional differences between isoforms. In this issue of Cancer Cell, Vila et al. report that UBE2O, a ubiquitin ligase overexpressed in some human cancers, specifically triggers the ubiquitination and degradation of AMPK-α2.

AB - There has been controversy regarding the role of AMPK in cancer, some of which may be due to functional differences between isoforms. In this issue of Cancer Cell, Vila et al. report that UBE2O, a ubiquitin ligase overexpressed in some human cancers, specifically triggers the ubiquitination and degradation of AMPK-α2.

U2 - 10.1016/j.ccell.2017.01.010

DO - 10.1016/j.ccell.2017.01.010

M3 - Article

VL - 31

SP - 163

EP - 165

JO - Cancer Cell

JF - Cancer Cell

SN - 1535-6108

IS - 2

ER -